Hercules PLC (LSE:HERC) has landed £6.2 million in new water-sector contracts across the Thames and Anglian regions. The work kicks off early in the company's 2026 financial year and strengthens its role as AMP8 spending ramps up. Read more
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF) is playing a key role in a £3.4 million programme tackling cytokine release syndrome (CRS). Its POLB 001 study stays on track for summer 2026, with the new partnership adding valuable clinical insights. Read more
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF)has started work to prepare flow testing at its ITW-1 well at its southern Rukwa project in Tanzania. Crews are on site ahead of installing an electrical pump that could confirm the project’s commercial potential. Read more
Frontier IP Group, PLC (LSE:FIPP) says long-term prospects look solid, but near-term uncertainty is still slowing progress. Annual losses widened as portfolio valuations dipped, though several holdings delivered notable technical and commercial advances. Read more
Tissue Regenix Group PLC (AIM:TRX) says it still can’t give clarity on its financial position ahead of its January delisting. The company expects to stay solvent if shareholders back new funding, with shares suspended until the cancellation takes effect. Read more
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
